Angiodynamics (ANGO) EBT Margin (2010 - 2026)
Angiodynamics' (ANGO) quarterly EBT Margin came in at 12.74% in Q2 2026, down 512.0% on a YoY basis from 3.09% in Q2 2025, and down 23.79% quarter-over-quarter from 10.29% in Q1 2026.
Powered by 
Analysis
Angiodynamics (ANGO) EBT Margin (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has reported EBT Margin for 17 consecutive years, with 12.74% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin fell 512.0% year-over-year to 12.74%; the trailing twelve-month figure through May 2026 stood at 11.34% (up 30.0% YoY), and the FY2026 full-year result was 11.34%, up 30.0% from the prior year.
- EBT Margin eased to 12.74% in Q2 2026 per ANGO's latest filing, from 10.29% in the prior quarter.
- Across five years, EBT Margin topped out at 44.31% in Q3 2023 and bottomed at 265.68% in Q1 2024.
- Historically, EBT Margin has averaged 23.84% across 5 years, with a median of 12.36% in 2023.
- The sharpest annual moves came in 2024 and 2025: EBT Margin sank 25370 bps in 2024, then surged 25955 bps in 2025.
- Over 5 years, EBT Margin stood at 10.59% in 2022, then slumped by 51 bps to 15.96% in 2023, then increased by 7 bps to 14.89% in 2024, then jumped by 46 bps to 8.0% in 2025, then plunged by 59 bps to 12.74% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 12.74%, 10.29%, and 8.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.32% |
| 10 | Angiodynamics | 633.27 Mn | 579.41 Mn | 46.77 Mn | -12.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -12.74% |
| Feb 28, 2026 | -10.29% |
| Nov 30, 2025 | -8.00% |
| Aug 31, 2025 | -14.31% |
| May 31, 2025 | -7.62% |
| Feb 28, 2025 | -6.12% |
| Nov 30, 2024 | -14.89% |
| Aug 31, 2024 | -18.77% |
| May 31, 2024 | -19.92% |
| Feb 29, 2024 | -265.68% |
| Nov 30, 2023 | -15.96% |
| Aug 31, 2023 | 44.31% |
| May 31, 2023 | -24.01% |
| Feb 28, 2023 | -11.97% |
| Nov 30, 2022 | -10.59% |
| Aug 31, 2022 | -16.99% |
| May 31, 2022 | -7.73% |
| Feb 28, 2022 | -7.78% |
| Nov 30, 2021 | -11.32% |
| Aug 31, 2021 | -11.18% |